These were the top performers this week, and Wall Street sees two of them gain another 30%.
This week’s top performers managed to post gains amid the market’s slump. All three major averages are on track to end the week lower, in what could be a negative third week in a row. Among the bright spots of the week were two names that Wall Street believes have much more room to run. DXC Technology stock is up 9.7% for the week to Thursday’s close. The stock is 32.4% above the average analyst price target. According to FactSet, prices for Bath & Body Works, which have gained more than 4% weekly so far, are up 31.4%. Here are the companies that have outperformed this week and where the analysts stand on stocks. To find these names, CNBC Pro looked for stocks in the space with the best performance from week to week. While DXC Technology and Bath & Body Works stand out as the names with the greatest potential upside, some other companies have returns that are double the price, according to the analyst average price target. Abbott Laboratories posted a gain of 18.6%, with 56.5% of analysts covering the stock as a buy. The healthcare company gained nearly 3% this week through Thursday. Ulta Beauty, which reported better-than-expected results for the fourth quarter last week, added just over 3% this week through Thursday. Raymond James chose the retailer as one of his top picks for consumer goods. UBS also highlighted Ulta as one of its highly condemned stocks that can outperform regardless of slowdown. According to the average price target of analysts, Ulta shares are up 14.6%. Meanwhile, Dollar General shares are up 2.7% this week through Thursday with another 10.5% gain, according to the average price target of analysts. Last week, the discount retailer raised its same-store sales guidance for the fiscal year. It is now higher than Wall Street expectations.